CCL2 and central nervous system cancer: Chen et al. confirmed the relevance of CCL2 in glioma patients by querying the TCGA database and showed that high CCL2 expression was associated with worse prognosis and shorter median survival compared to patients who exhibited low expression of CCL2 (11).